The company is recalling the antibiotic due to a lack of potency, meaning there’s less of the antibiotic available in the body to fight infections, which can lead to treatment failures. A lack of potency could result in rapid progression of the infection and death, the drugmaker warned.
Avet hasn’t received any adverse event reports related to the recall.
Patients with compromised immune systems often take tetracycline to treat serious infections such as pneumonia. The drugs are made by Avet Pharmaceuticals and sold under the company’s Heritage Pharmaceuticals label.
Read the full news release here.
More articles on pharmacy:
CVS, UCLA Health unite to free hospital beds for COVID-19 patients
NIH teams up with 16 drugmakers to speed COVID-19 vaccine development
16 recent drug, device recalls
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
